F Chatelanat

683 total citations
35 papers, 326 citations indexed

About

F Chatelanat is a scholar working on Rheumatology, Nephrology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, F Chatelanat has authored 35 papers receiving a total of 326 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Rheumatology, 10 papers in Nephrology and 8 papers in Pulmonary and Respiratory Medicine. Recurrent topics in F Chatelanat's work include Renal Diseases and Glomerulopathies (10 papers), Systemic Lupus Erythematosus Research (8 papers) and Vasculitis and related conditions (5 papers). F Chatelanat is often cited by papers focused on Renal Diseases and Glomerulopathies (10 papers), Systemic Lupus Erythematosus Research (8 papers) and Vasculitis and related conditions (5 papers). F Chatelanat collaborates with scholars based in Switzerland, France and United States. F Chatelanat's co-authors include H Favre, Michael J. Mihatsch, P Miescher, Yabing Huang, A Cruchaud, P. A. Miescher, Y. Mérot, Gérard Simon, J.A. Schifferli and Peter M. Ndumbe and has published in prestigious journals such as The American Journal of Medicine, The Journal of Urology and Journal of Molecular Medicine.

In The Last Decade

F Chatelanat

28 papers receiving 285 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
F Chatelanat Switzerland 10 141 122 64 51 51 35 326
R. M. McIntosh United States 10 50 0.4× 133 1.1× 96 1.5× 54 1.1× 36 0.7× 27 370
B Weil France 12 66 0.5× 264 2.2× 95 1.5× 70 1.4× 110 2.2× 37 485
Clive L. Hall United Kingdom 12 41 0.3× 80 0.7× 78 1.2× 39 0.8× 58 1.1× 20 327
Mary G. Beale United States 10 74 0.5× 80 0.7× 216 3.4× 48 0.9× 36 0.7× 15 441
A O Haakenstad United States 8 83 0.6× 102 0.8× 181 2.8× 90 1.8× 15 0.3× 9 447
Cohen Ah United States 9 53 0.4× 219 1.8× 49 0.8× 111 2.2× 26 0.5× 15 450
A Zlotnick Israel 12 87 0.6× 21 0.2× 64 1.0× 97 1.9× 34 0.7× 37 371
Nurit Vardinon Israel 10 163 1.2× 41 0.3× 118 1.8× 23 0.5× 12 0.2× 14 395
L. A. van Es Netherlands 7 37 0.3× 158 1.3× 179 2.8× 55 1.1× 14 0.3× 8 369
Cassyanne L. Aguiar United States 9 318 2.3× 71 0.6× 99 1.5× 73 1.4× 33 0.6× 11 466

Countries citing papers authored by F Chatelanat

Since Specialization
Citations

This map shows the geographic impact of F Chatelanat's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F Chatelanat with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F Chatelanat more than expected).

Fields of papers citing papers by F Chatelanat

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by F Chatelanat. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F Chatelanat. The network helps show where F Chatelanat may publish in the future.

Co-authorship network of co-authors of F Chatelanat

This figure shows the co-authorship network connecting the top 25 collaborators of F Chatelanat. A scholar is included among the top collaborators of F Chatelanat based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with F Chatelanat. F Chatelanat is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chatelanat, F. (2000). [Lesion topography in the case of necrotizing angiitis].. PubMed. 2(4). 505–28.
2.
Jlidi, R, et al.. (1991). [Carcinosarcoma of the urinary bladder and renal metastasis].. PubMed. 11(1). 42–6. 3 indexed citations
3.
Favre, H, P Miescher, Yabing Huang, F Chatelanat, & Michael J. Mihatsch. (1989). Ciclosporin in the Treatment of Lupus Nephritis. American Journal of Nephrology. 9(1). 57–60. 67 indexed citations
4.
Pa, Miescher, et al.. (1988). The place of cyclosporine A in the treatment of connective tissue diseases.. PubMed. 20(3 Suppl 4). 224–37. 23 indexed citations
5.
Stamenkovic, Ivan, H Favre, A Donath, A. Assimacopoulos, & F Chatelanat. (1987). Renal Biopsy in SLE Irrespective of Clinical Findings: Long-Term Follow-Up. The Journal of Urology. 137(6). 1328–1328. 8 indexed citations
6.
Miescher, P. A., H Favre, F Chatelanat, & Michael J. Mihatsch. (1987). Combined steroid-cyclosporin treatment of chronic autoimmune diseases. Journal of Molecular Medicine. 65(15). 727–736. 35 indexed citations
7.
Stamenkovic, Ivan, H Favre, A Donath, A. Assimacopoulos, & F Chatelanat. (1986). Renal biopsy in SLE irrespective of clinical findings: long-term follow-up.. PubMed. 26(3). 109–15. 14 indexed citations
8.
Chatelanat, F, et al.. (1985). [Renal puncture biopsy in the aged subject: apropos of 119 cases].. PubMed. 5(2). 101–5. 3 indexed citations
9.
Chatelanat, F, et al.. (1985). [Association of adenocarcinoma of the prostate with transitional carcinoma of the bladder].. PubMed. 52(3-4). 533–4. 1 indexed citations
10.
Chatelanat, F, et al.. (1984). [Bilateral renal oncocytoma].. PubMed. 5(2). 83–6. 5 indexed citations
11.
Mérot, Y., et al.. (1983). Glomérulonéphrite et pemphigoïde bulleuse: deux observations.. Annales de Dermatologie et de Vénéréologie. 110(9). 2 indexed citations
12.
Mérot, Y., et al.. (1983). [Glomerulonephritis and bullous pemphigoid: 2 cases].. PubMed. 110(9). 739–40. 8 indexed citations
13.
Favre, H, F Chatelanat, & P. A. Miescher. (1979). Autoimmune hematologic diseases associated with infraclinical systemic lupus erythematosus in four patients. The American Journal of Medicine. 66(1). 91–95. 10 indexed citations
14.
Favre, H, et al.. (1977). Glomerulonephritis associated with hepatitis B. report of a case and review of the literature.. PubMed. 8(3). 404–9. 18 indexed citations
15.
Cruchaud, A, et al.. (1975). Immune Complex Deposits in Systemic Lupus Erythematosus Kidney without Histological or Functional Alterations†. European Journal of Clinical Investigation. 5(1). 297–309. 20 indexed citations
16.
Cruchaud, A, et al.. (1975). Immune Complex Deposits in Systemic Lupus Erythematosus Kidney without Histological or Functional Alterations†. European Journal of Clinical Investigation. 5(3). 297–309. 1 indexed citations
17.
Dayer, J.-M., et al.. (1974). Sclérodermie, insuffisance rénale, hypertension accélérée et anémie hémolytique microangiopathique. Schweizerische medizinische Wochenschrift. 104(24). 1 indexed citations
18.
Laugier, P, et al.. (1971). [Disseminated lupus erythematosus, induced by estrogens. Viral inclusions revealed by renal biopsy].. PubMed. 78(6). 623–8.
19.
Chatelanat, F & Gérard Simon. (1965). N�phropathie dans un cas d'ost�olyse essentielle Etude aux microscopes optique et �lectronique. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 339(3). 262–274. 2 indexed citations
20.
Simon, Gérard, et al.. (1964). EXPERIMENTAL NEPHROSIS DUE TO INULIN: LIGHT AND ELECTRON MICROSCOPIC STUDIES.. PubMed. 13. 1381–93. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026